申请人:Coley Pharmaceutical GmbH
公开号:EP1985702A2
公开(公告)日:2008-10-29
Immunostimulatory compositions described as CpG-like nucleic acids are provided, including nucleic acids having immunostimulatory characteristics of CpG nucleic acid, despite certain substitutions of C, G, or C and G of the CpG dinucleotide. The substitutions can include, among others, exchange of methylated C for C, inosine for G, and ZpY for CpG, where Z is Cytosine or dSpacer and Y is inosine, 2-aminopurine, nebularine, or dSpacer. Also provided are methods for inducing an immune response in a subject using the CpG-like nucleic acids. The methods are useful in the treatment of a subject that has or is at risk of developing an infectious disease, allergy, asthma, cancer, anemia, thrombocytopenia, or nutropenia.
提供了被描述为 CpG 样核酸的免疫刺激组合物,包括具有 CpG 核酸免疫刺激特性的核酸,尽管 CpG 二核苷酸的 C、G 或 C 和 G 有某些替换。除其他外,这些取代可包括将甲基化的 C 换成 C,将肌苷换成 G,将 ZpY 换成 CpG,其中 Z 是胞嘧啶或 dSpacer,Y 是肌苷、2-氨基嘌呤、奈伯碱或 dSpacer。还提供了使用 CpG 样核酸诱导受试者免疫应答的方法。这些方法可用于治疗患有传染病、过敏症、哮喘、癌症、贫血、血小板减少症或营养不良症的受试者。